Induction by staurosporine of hepatocyte growth factor production in human skin fibroblasts independent of protein kinase inhibition

Biochemical Pharmacology

Volumn 66, Issue 9, 2003, Pages 1797-1808

  Yagi, Yasuyuki ^a   Sotani, Tomohiro ^a   Nagao, Toshinori ^a   Horio, Tomoyo ^a   Yamamoto, Itaru ^a   Gohda, Eiichi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Cyclic AMP; Hepatocyte growth factor; Human fibroblast; Induction; Staurosporine; UCN 01

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 7 HYDROXYSTAUROSPORINE; 8 BROMO CYCLIC AMP; CHOLERA TOXIN; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GENISTEIN; K 252A; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; SCATTER FACTOR; STAUROSPORINE;

ARTICLE; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFANT; MALE; NEWBORN; PRIORITY JOURNAL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; UPREGULATION;

EID: 0141888288     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00547-1     Document Type: Article

References (60)

1. Strain A.J., McGowan J.A., Bucher N.L.R. Stimulation of DNA synthesis in primary cultures of adult rat hepatocytes by rat platelet-associated substance(s). In Vitro. 18:1982;108-116.
2. Michalopoulos G., Cianciulli H.D., Novotny A.R., Kligerman A.D., Strom S.C., Jirtle R.L. Liver regeneration studies with rat hepatocytes in primary culture. Cancer Res. 42:1982;4673-4682.
3. Gohda E., Tsubouchi T., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Miyazaki H., Hashimoto S., Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J. Clin. Invest. 81:1988;414-419.
4. Nakamura T., Nawa K., Ichihara A., Kaise N., Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 224:1987;311-316.
5. Zarnegar R., Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 49:1989;3314-3320.
6. Miyazawa K., Tsubouchi H., Naka D., Takahashi K., Okigaki M., Arakaki N., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Gohda E., Daikuhara Y., Kitamura N. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys Res. Commun. 163:1989;967-973.
7. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:1989;440-443.
8. Gohda E., Nakamura S., Yamamoto I., Minowada J. Hepatocyte growth factor-pleiotropic cytokine produced by human leukemia cells. Leuk. Lymphoma. 19:1995;197-205.
9. Michalopoulos G.K., DeFrances M.C. Liver regeneration. Science. 276:1997;60-66.
10. Gohda E., Yamasaki T., Tsubouchi H., Kurobe M., Sakiyama O., Aoki H., Niidani N., Shin S., Hayashi K., Hashimoto S., Daikuhara Y., Yamamoto I. Biological and immunological properties of human hepatocyte growth factor from plasma of patients with fulminant hepatic failure. Biochim. Biophys. Acta. 1053:1990;21-26.
11. Ishiki Y., Ohnishi H., Muto Y., Matsumoto K., Nakamura T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology. 16:1992;1227-1235.
12. Fujiwara K., Nagoshi S., Ohno A., Hirata K., Ohta Y., Mochida S., Tomiya T., Higashio K., Kurokawa K. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology. 18:1993;1443-1449.
13. Ishii T., Sato M., Sudo K., Suzuki M., Nakai H., Hishida T., Niwa T., Umezu K., Yuasa S. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J. Biochem. (Tokyo). 117:1995;1105-1112.
14. Shiota G., Wang T.C., Nakamura T., Schmidt E.V. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression. Hepatology. 19:1994;962-972.
15. Asami O., Ihara I., Shimidzu N., Shimizu S., Tomita Y., Ichihara A., Nakamura T. Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats. J. Biochem. (Tokyo). 109:1991;8-13.
16. Lindroos P.M., Zarnegar R., Michalopoulos G.K. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 13:1991;743-749.
17. Okajima A., Miyazawa K., Kitamura N. Primary structure of rat hepatocyte growth factor and induction of its mRNA during liver regeneration following hepatic injury. Eur. J. Biochem. 193:1990;375-381.
18. Zarnegar R., DeFrances M.C., Kost D.P., Lindroos P., Michalopoulos G.K. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem. Biophys. Res. Commun. 177:1991;559-565.
19. Yanagita K., Nagaike M., Ishibashi H., Niho Y., Matsumoto K., Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem. Biophys. Res. Commun. 182:1992;802-809.
20. Higuchi O., Nakamura T. Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis. Biochem. Biophys. Res. Commun. 176:1991;599-607.
21. Burr A.W., Toole K., Chapman C., Hines J.E., Burt A.D. Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration. J. Pathol. 185:1998;298-302.
22. Schmidt C., Bladt F., Goedecke S., Brinkmann V., Zschiesche W., Sharpe M., Gherardi E., Birchmeier C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature. 373:1995;699-702.
23. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 327:1987;239-242.
24. 3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. Blood. 82:1993;53-59.
25. Matsunaga T., Gohda E., Takebe T., Wu Y.L., Iwao M., Kataoka H., Yamamoto I. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway. Exp. Cell Res. 210:1994;326-335.
26. Gohda E., Kataoka H., Tsubouchi H., Daikuhara Y., Yamamoto I. Phorbol ester-induced secretion of human hepatocyte growth factor by human skin fibroblasts and its inhibition by dexamethasone. FEBS Lett. 301:1992;107-110.
27. Tamura M., Arakaki N., Tsubouchi H., Takada H., Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1α and -1β and tumor necrosis factor-α by fibroblasts in culture. J. Biol. Chem. 268:1993;8140-8145.
28. Gohda E., Takebe T., Sotani T., Nakamura S., Minowada J., Yamamoto I. Induction of hepatocyte growth factor/scatter factor by interferon-γ in human leukemia cells. J. Cell Physiol. 174:1998;107-114.
29. Liu Y., Lin L., Zarnegar R. Modulation of hepatocyte growth factor gene expression by estrogen in mouse ovary. Mol. Cell Endocrinol. 104:1994;173-181.
30. Wu Y.L., Gohda E., Iwao M., Matsunaga T., Nagao T., Takebe T., Yamamoto I. Stimulation of hepatocyte growth factor production by ascorbic acid and its stable 2-glucoside. Growth Horm. IGF Res. 8:1998;421-428.
31. Gohda E., Nagao T., Yamamoto I. Stimulation of hepatocyte growth factor production in human fibroblasts by the protein phosphatase inhibitor okadaic acid. Biochem. Pharmacol. 60:2000;1531-1537.
32. Broten J., Michalopoulos G., Petersen B., Cruise J. Adrenergic stimulation of hepatocyte growth factor expression. Biochem. Biophys. Res. Commun. 262:1999;76-79.
33. Rosen E.M., Joseph A., Jin L., Rockwell S., Elias J.A., Knesel J., Wines J., McClellan J., Kluger M.J., Goldberg I.D., Zitnik R. Regulation of scatter factor production via a soluble inducing factor. J. Cell Biol. 127:1994;225-234.
34. Koniaris L.G., Zimmers-Koniaris T., Hsiao E.C., Chavin K., Sitzmann J.V., Farber J.M. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J. Immunol. 167:2001;399-406.
35. Gohda E., Matsunaga T., Kataoka H., Takebe T., Yamamoto I. Induction of hepatocyte growth factor in human skin fibroblasts by epidermal growth factor, platelet-derived growth factor and fibroblast growth factor. Cytokine. 6:1994;633-640.
36. Omura S., Sasaki Y., Iwai Y., Takeshima H. Staurosporine, a potentially important gift from a microorganism. J. Antibiot. 48:1995;535-548.
37. Nakamura S., Gohda E., Matsunaga T., Yamamoto I., Minowada J. Production of hepatocyte growth factor by human haematopoietic cell lines. Cytokine. 6:1994;285-294.
38. Tsubouchi H., Niitani Y., Hirono S., Nakayama H., Gohda E., Arakaki N., Sakiyama O., Takahashi K., Kimoto M., Kawakami S., Setoguchi M., Tachikawa T., Shin S., Arima T., Daikuhara Y. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology. 13:1991;1-5.
39. Bensadoun A., Weinstein D. Assay of proteins in the presence of interfering materials. Anal. Biochem. 70:1976;241-250.
40. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
41. Gohda E., Kuromitsu K., Matsunaga T., Miyazaki M., Yamamoto I. Synergism between interferon-γ and cAMP in induction of hepatocyte growth factor in human skin fibroblasts. Cytokine. 12:2000;780-785.
42. Lindroos P.M., Wang Y.Z., Rice A.B., Bonner J.C. Regulation of PDGFR-α in rat pulmonary myofibroblasts by staurosporine. Am. J. Physiol. Lung Cell Mol. Physiol. 280:2001;L354-L362.
43. Xiao Y.Q., Someya K., Morita H., Takahashi K., Ohuchi K. Involvement of p38 MAPK and ERK/MAPK pathways in staurosporine-induced production of macrophage inflammatory protein-2 in rat peritoneal neutrophils. Biochim. Biophys. Acta. 1450:1999;155-163.
44. Seynaeve C.M., Kazanietz M.G., Blumberg P.M., Sausville E.A., Worland P.J. Differential inhibition of protein kinase C isozymes by UCN-01, a staurosporine analogue. Mol. Pharmacol. 45:1994;1207-1214.
45. Friedman B., Fujiki H., Rosner M.R. Regulation of the epidermal growth factor receptor by growth-modulating agents: effects of staurosporine, a protein kinase inhibitor. Cancer Res. 50:1990;533-538.
46. Ramamoorthy J.D., Ramamoorthy S., Papapetropoulos A., Catravas J.D., Leibach F.H., Ganapathy V. Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells. J. Biol. Chem. 270:1995;17189-17195.
47. Buc H.-A., Moncion A., Pérignon J.-L. Staurosporine and herbimycin A augment agonist-induced elevation of cAMP in Jurkat T-lymphoblasts. Int. J. Immunopharmacol. 18:1996;135-139.
48. Pedron T., Girard R., Inoue K., Charon D., Chaby R. Lipopolysaccharide and the glycoside ring of staurosporine induce CD14 expression on bone marrow granulocytes by different mechanisms. Mol. Pharmacol. 52:1997;692-700.
49. Pedron T., Girard R., Chaby R. Exogenous cyclic AMP, cholera toxin, and endotoxin induce expression of the lipopolysaccharide receptor CD14 in murine bone marrow cells: role of purinoreceptors. Clin. Diagn. Lab. Immunol. 6:1999;885-890.
50. Wang C.Y., Lei H.J., Huang C.Y.F., Zhang Z., Mukherjee A.B., Yuan C.J. Induction of cyclooxygenase-2 by staurosporine through the activation of nuclear factor for IL-6 (NF-IL6) and activator protein 2 (AP2) in an osteoblast-like cell line. Biochem. Pharmacol. 64:2002;177-184.
51. Tang Q., Chen W., Gonzales M.S., Finch J., Inoue H., Bowden G.T. Role of cyclic AMP responsive element in the UVB induction of cyclooxygenase-2 transcription in human keratinocytes. Oncogene. 20:2001;5164-5172.
52. Hecker M., Preiß C., Schini-Kerth V.B. Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-κB, CREB and C/EBPβ Br. J. Pharmacol. 120:1997;1067-1074.
53. Jiang J.G., Zarnegar R. A novel transcriptional regulatory region within the core promoter of the hepatocyte growth factor gene is responsible for its inducibility by cytokines via the C/EBP family of transcription factors. Mol. Cell Biol. 17:1997;5758-5770.
54. Umayahara Y., Ji C., Centrella M., Rotwein P., McCarthy T.L. CCAAT/enhancer-binding protein δ activates insulin-like growth factor-I gene transcription in osteoblasts: identification of a novel cyclic AMP signaling pathway in bone. J. Biol. Chem. 272:1997;31793-31800.
55. 2+/calmodulin kinases activation in hippocampal neurons. J. Biol. Chem. 273:1998;31345-31351.
56. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., Lee J.C. SB203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stress and interleukin-1. FEBS Lett. 364:1995;229-233.
57. Börsch-Haubold A.G., Pasquet S., Watson S.P. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J. Biol. Chem. 273:1998;28766-28772.
58. Miyazaki M., Gohda E., Kaji K., Namba M. Increased hepatocyte growth factor production by aging human fibroblasts mainly due to autocrine stimulation by interleukin-1. Biochem. Biophys. Res. Commun. 246:1998;255-260.
59. Yasuda H., Imai E., Shiota A., Fujise N., Morinaga T., Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology. 24:1996;636-642.
60. Mizuno S., Kurosawa T., Matsumoto K., Mizuno-Horikawa Y., Okamoto M., Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J. Clin. Invest. 101:1998;1827-1834.